neuroClues
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
neuroClues provides easy-to-use eye-tracking environment.
HQ Location
Belgium
Founded
2020
Employees
11 - 50
Total funding raised
$12.68M
Last Funding Event
Seed, $5.33M, April 30, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Operator of a MedTech company aiming to become the brain's stethoscope while revolutionizing the early diagnosis of neurological disorders such as Parkinson's and Alzheimer's. The company is (Artificial Intelligence) AI-driven eye-tracking technology it provides non-invasive, accessible solutions for clinicians to detect brain health issues earlier, improving patient outcomes and treatment strategies.